Acelot is a biopharmaceutical company that provides therapies for nervous system disorders.
Acelot is a life science-based R&D company on advanced technology for drug discovery. This technology is made available as a web-based drug discovery platform, employed in-house for some drug-discovery projects in the central nervous system area. It allows the identification of latent pharmacophore information and can be used for rapid identification and optimization of drug development projects without clear target information or crystallography data.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 26, 2013 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |